Literature DB >> 3828823

Cerebrovascular and metabolic changes during the delayed vasospasm following experimental subarachnoid hemorrhage in baboons, and treatment with a calcium antagonist.

C Sahlin, J Brismar, T Delgado, C Owman, L G Salford, N A Svendgaard.   

Abstract

A model has been designed in baboons for simulating the clinical situation during the late phase of vasospasm in patients with subarachnoid hemorrhage (SAH). A total amount of 14-33 ml autologous blood was injected into the cisternal system on 3 occasions in the course of 4 days. Neurological symptoms were seen, and the mortality rate was 29%. Angiography 3 days after the last injection showed arterial vasoconstriction amounting to 23% in the vertebro-basilar system, and 11% (right) and 18% (left) in the carotid system. Cerebral blood flow (CBF) measured by the intra-arterial 133Xe technique and the cerebral metabolic rate of oxygen (CMRO2) were reduced by 18% and 11%, respectively. The hypercapnic CBF response was significantly impaired, from a mean of 3.90 ml/100 g/min to 1.72 ml/100 g/min of flow increase for each mm Hg elevation of paCO2. Autoregulation, tested by administration of angiotensin II, was also significantly affected as evidenced by a pressure-dependent increment of CBF during hypertension in 5 out of 7 animals tested. The impaired autoregulation was reflected in the autoregulatory index, which in the whole group increased from 0.06 ml/100 g/min for each mm Hg increase in MABP in the pre-SAH animals to 0.29 ml/100 g/min per mm Hg post-SAH. Treatment with the calcium antagonist, nimodipine (0.5 microgram/kg/min i.v. during 45 min), enhanced CBF significantly by 17% before experimental SAH, whereas after SAH the effect was slight and did not reach statistical significance; CMRO2 was not significantly affected in either group. Intravenous nimodipine combined with hypertension resulted in a marked increase in the autoregulatory index to 1.58 ml/100 g/min per mm Hg in pre-SAH animals and a less pronounced increment to 0.58 ml/100 g/min per mm Hg following experimental SAH. The beneficial effect of nimodipine reported in SAH patients is therefore, in view of our findings, more likely due primarily to a protective mechanism at the cellular level than to an influence on the vascular bed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3828823     DOI: 10.1016/0006-8993(87)90069-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Cerebrovascular autoregulation is resistant to calcium channel blockade with nimodipine.

Authors:  T A McCalden; R G Nath
Journal:  Experientia       Date:  1989-03-15

2.  The effect of nimodipine on autoregulation of cerebral blood flow after subarachnoid haemorrhage in rat.

Authors:  J Hauerberg; G Rasmussen; M Juhler; F Gjerris
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

3.  A primate model for acute and late cerebral vasospasm: angiographic findings.

Authors:  T J Delgado-Zygmunt; M A Arbab; Y Shiokawa; N A Svendgaard
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

4.  Cerebral blood flow autoregulation in experimental subarachnoid haemorrhage in rat.

Authors:  G Rasmussen; J Hauerberg; G Waldemar; F Gjerris; M Juhler
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

5.  Dynamic CT perfusion imaging in subarachnoid hemorrhage-related vasospasm.

Authors:  A M Laslo; J D Eastwood; F-X Chen; T-Y Lee
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

6.  Nimodipine has no effect on the cerebral circulation in conscious pigs, despite an increase in cardiac output.

Authors:  W J van der Giessen; D J Duncker; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

Review 7.  Calcium Channel Blockers in Acute Care: The Links and Missing Links Between Hemodynamic Effects and Outcome Evidence.

Authors:  Jin Wang; David L McDonagh; Lingzhong Meng
Journal:  Am J Cardiovasc Drugs       Date:  2021-01       Impact factor: 3.571

8.  Cerebral blood flow and glucose metabolism in the squirrel monkey during the late phase of cerebral vasospasm.

Authors:  T Delgado-Zygmunt; M A Arbab; Y Shiokawa; N A Svendgaard
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

9.  Global and regional brain metabolic scaling and its functional consequences.

Authors:  Jan Karbowski
Journal:  BMC Biol       Date:  2007-05-09       Impact factor: 7.431

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.